Radiation Oncology/Therapy: Page 46

Radiation therapy for breast cancer boosts risk of heart disease

By Amerigo Allegretto

Women who undergo radiation therapy to the left side of the chest to treat breast cancer are at twice the risk for coronary artery disease, according to research published September 21 in the Journal of the American College of Cardiology.

September 20, 2021

BWXT and Bayer to focus on therapeutic radionuclides

By AuntMinnie.com staff writers

BWXT Medical and Bayer have entered an agreement to ramp up their supply of actinium-225 as both companies seek to broaden commercialization strategies for targeted radionuclide therapies.

September 15, 2021

IBA, SCK CEN sign actinium-225 deal

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225.

September 14, 2021

Accuray promotes prostate cancer research at ESTRO 2021

By AuntMinnie.com staff writers

Radiation oncology firm Accuray is highlighting research presented at the recent European Society for Radiotherapy and Oncology (ESTRO) annual congress on the benefits of its CyberKnife robotic radiotherapy platform in prostate cancer treatment.

September 13, 2021

Lantheus, RefleXion to collaborate on prostate cancer treatment

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent Lantheus Holdings and radiation therapy equipment developer RefleXion Medical have signed a development and marketing partnership to evaluate the use of Lantheus' prostate-specific membrane antigen-targeted PET agent piflufolastat F-18 with RefleXion's X1 biology-guided radiotherapy system.

September 12, 2021

B dot Medical unveils scanning magnet for proton therapy

By AuntMinnie.com staff writers

B dot Medical has manufactured a scanning magnet for a compact proton therapy system currently under development.

September 9, 2021

PET identifies early responders to liver cancer treatment

By Will Morton

PET imaging can predict how liver cancer patients are going to respond early after transarterial radioembolization, according to a study published online September 8 in the American Journal of Roentgenology.

September 9, 2021

ASTRO calls proposed CMS cuts 'draconian'

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) told the U.S. Centers for Medicare and Medicaid Services (CMS) that its proposed changes to the 2022 Medicare Physician Fee Schedule could lead to draconian cuts in cancer care.

September 8, 2021

NorthStar, Point Biopharma ink Ac-225 supply deal

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and Point Biopharma Global have signed a supply agreement covering the development and commercialization of the medical radioisotope actinium-225 (Ac-225).

September 7, 2021

Telix, Kettering to research PSMA radiotracer

By AuntMinnie.com staff writers

Kettering Health and Telix Pharmaceuticals have signed a deal to study Telix's investigational prostate-specific membrane antigen (PSMA)-targeting radiopharmaceutical, illuccix.

September 7, 2021

Hermes, Isotopia sign deal on dosimetry

By AuntMinnie.com staff writers

Nuclear medicine software developer Hermes Medical Solutions has signed a collaboration with Isotopia Molecular Imaging to support clinical studies to demonstrate the positive effects of personalized dosimetry and modulated radiopharmaceutical therapy on patient outcomes.

September 6, 2021

Akumin closes on Alliance acquisition

By AuntMinnie.com staff writers

Akumin has completed its acquisition of Alliance HealthCare Services, a national provider of radiology and oncology services to hospitals, health systems, and physician groups.

September 1, 2021

Previous Page

Page 46 of 465

Next Page